Intelligent platelet inhibitors are on the horizon

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 31, Issue 9, 2011, Pages 1949-1950

  Gawaz, Meinrad ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

glycoprotein IIb IIIa platelet inhibitors; platelet receptor blockers; platelets; thrombosis

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; EPTIFIBATIDE; FIBRINOGEN RECEPTOR; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOGEN RECEPTOR SINGLE CHAIN FRAGMENT C ELASTIN MIMETIC POLYPEPTIDE; HYBRID PROTEIN; TIROFIBAN; UNCLASSIFIED DRUG;

ARTERY THROMBOSIS; BLEEDING TIME; DRUG ACTIVITY; DRUG RECEPTOR BINDING; DRUG TARGETING; EDITORIAL; INDUCED HYPOTHERMIA; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SEPSIS; TEMPERATURE SENSITIVITY; THROMBOCYTE AGGREGATION;

ANIMALS; HUMANS; HYPOTHERMIA, INDUCED; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; RECOMBINANT FUSION PROTEINS; TROPOELASTIN;

EID: 80052178583     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.111.232173     Document Type: Editorial

References (7)

1. Geisler T, Gawaz M, Steinhubl SR, Bhatt DL, Storey RF, Flather M. Current strategies in antiplatelet therapy-does identification of risk and adjustment of therapy contribute to more effective, personalized medicine in cardiovascular disease? Pharmacol Ther. 2010;127:95-107.
2. Topcic D, Kim W, Holien JK, Jia F, Armstrong PC, Hohmann JD, Straub A, Krippner G, Haller CA, Domeij H, Hagemeyer CE, Parker MW, Chaikof EL, Peter K. An activation-specific platelet inhibitor that can be turned on/off by medically used hypothermia. Arterioscler Thromb Vasc Biol. 2011;31:2015-2023.
3. Gawaz M, Neumann FJ, Schomig A. Evaluation of platelet membrane glycoproteins in coronary artery disease: consequences for diagnosis and therapy. Circulation. 1999;99:E1-E11.
4. Schwarz M, Meade G, Stoll P, Ylanne J, Bassler N, Chen YC, Hagemeyer CE, Ahrens I, Moran N, Kenny D, Fitzgerald D, Bode C, Peter K. Conformationspecific blockade of the integrin GPIIb/IIIa: a novel antiplatelet strategy that selectively targets activated platelets. Circ Res. 2006;99:25-33. (Pubitemid 44297052)
5. Reiersen H, Clarke AR, Rees AR. Short elastin-like peptides exhibit the same temperature-induced structural transitions as elastin polymers: implications for protein engineering. J Mol Biol. 1998;283:255-264. (Pubitemid 28466654)
6. Gawaz M, Fateh-Moghadam S, Pilz G, Gurland HJ, Werdan K. Severity of multiple organ failure (MOF) but not of sepsis correlates with irreversible platelet degranulation. Infection. 1995;23:16-23.
7. Ungerer M, Rosport K, Bültmann A, Piechatzek R, Uhland K, Schlieper P, Gawaz M, Münch G. Novel antiplatelet drug revacept (dimeric glycoprotein VI-Fc) specifically and efficiently inhibited collagen-induced platelet aggregation without affecting general hemostasis in humans. Circulation. 2011;123:1891-1899.